New treatments for perioperative cardiac arrhythmias

Laura A Hastings1, Jeffrey R Balser

  • 1Department of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA.

Insights

Cardiac arrhythmias are a significant risk for surgical patients. Further research into perioperative proarrhythmic substrates is needed to guide antiarrhythmic drug therapy.

Area of Science:

  • Cardiology
  • Perioperative Medicine
  • Pharmacology

Background:

  • Cardiac arrhythmias contribute significantly to surgical patient morbidity and mortality.
  • Existing research on cardiac arrhythmia management primarily focuses on out-of-hospital cardiac arrest scenarios.
  • There is a gap in understanding the specific proarrhythmic factors in the surgical population.

Purpose of the Study:

  • To highlight the need for research into cardiac arrhythmias in surgical patients.
  • To identify the unique proarrhythmic substrates relevant to the perioperative period.
  • To establish a rationale for perioperative antiarrhythmic drug therapy.

Main Methods:

  • Review of recent studies on cardiac arrhythmia management.
  • Analysis of knowledge gaps concerning surgical patients.
  • Identification of proarrhythmic substrates in the perioperative setting.

Main Results:

  • Cardiac arrhythmias pose a major threat to surgical patient outcomes.
  • Current knowledge on arrhythmia management is largely derived from non-surgical contexts.
  • Specific proarrhythmic substrates in surgical patients are not well-defined.

Conclusions:

  • Further investigation into perioperative proarrhythmic substrates is crucial.
  • Developing targeted antiarrhythmic drug strategies for surgical patients requires dedicated research.
  • Understanding unique patient factors is key to improving perioperative cardiac care.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...